Editor-in-Chief:

Ryuichi Morishita
Department of Clinical Gene Therapy
School of Medicine, Osaka University
2-2 Yamada-oka, Suita 565-0871
Japan

Associate Editors:

B.M. Forman (Diabetes Research Center, RoadDuarte, CA, USA)
G.D. Kitas (Dudley Group of Hospitals NHS Trust, Dudley, UK)
E.J. Schaefer (New England Medical Center, Boston, MA, USA)
T.M. Willson (GlaxoSmithKline, USA)

Editorial Advisory Board:

F.Q. Alenzi (Prince Salman University, Al-Kharj, Saudi Arabia)
G. Aliev (Javeriana University, Bogota, Colombia, USA)
A. Allera (University of Bonn, Bonn, Germany)
C.M. Arbeeny (Genzyme Corporation , Framingham, MA, USA)
P.M. Aviram (Rambam Medical Center, Haifa, Isreal)
S.K. Baniwal (University of Southern California (USC), Los Angeles, USA)
J. Bełtowski (Medical University, Lublin, Poland)
L.P. Braxton (Corgentech Inc., Palo Alto, CA, USA)
M.R. Briggs (Pharmacia Corporation, St. Louis, MO, USA)
G.A. Camejo (AstraZeneca R&D, Molndal, Sweden)
G.N. Chaldakov (Medical University, Varna, Bulgaria)
H.W. Chu (National Jewish Health, Denver, Colorado, CO, USA)
P.J. Davis (Ordway Research Institute, Inc. Albany, NY, USA)
C. DiRusso (University of Nebraska-Lincoln, Lincoln, Nebraska, USA)
H.H. Dong (University of Pittsburgh, Pittsburgh, PA, USA)
M.R. Emmerling (Pfizer Global Research & Development, Ann Arbor, MI, USA)
M. Fiore (Istituto di Neurobiologia e Medicina Molecolare, Roma, Italy)
W.G. Foster (McMaster University, Hamilton, Canada)
M. Heiman (Lilly Corporate Center, Indianapolis, IN, USA)
A. Ichihara (Keio University, Tokyo, Japan)
L. Iuliano (La Sapienza University, Latina, Italy)
T. Iwasaki (Hyogo College of Medicine, Hyogo, Japan)
E. Jeung (Chungbuk National University, Chungbuk, South Korea)
E. Karnieli (Rambam Medical Center, Haifa, Israel)
M. Khan (University of Warwick, Coventry, UK)
H.-S. Kim (Seoul National University Hospital, Seoul, South Korea)
M.L. Koschinsky (Queen's University, Kingston, NY, USA)
K.F. Kozarsky (GlaxoSmithKline Company, King of Prussia, PA, USA)
B.R. Krause (Pfizer Global Research And Development, Ann Arbor, MI, USA)
J.H. Lazarus (University Hospital of Wales, Heath Park, Cardiff, UK)
S.P. Little (Eli Lilly and Company, Indianapolis, IN, USA)
R.A. Mageed (Queen Mary University of London, London, UK)
M. Maggiolini (University of Calabria, Rende, Cosenza Italy)
K. Masuo (Baker IDI Heart & Diabetes Institute, Melbourne,  Victoria, Australia)
M. Marino (University of Roma, Roma, Italy)
D.F. Mierke (Brown University, Providence, RI, USA)
M. Moreno (University of Sannio, Benevento, Italy)
G. Muller (Sanofi-Aventis Pharma, Frankfurt, Germany)
H. Nakagami (Osaka University Graduate School of Medicine, Osaka, Japan)
E.J. Niesor (F.Hoffmann-La Roche Ltd., Basel, Switzerland)
J.L. Pérez-Castrillón (Hospital Río Hortega Cardenal Torquemada,  Valladolid, Spain)
P.H. Reddy (Oregon Health and Science University, Beaverton, OR, USA)
V.P. Reddy (Missouri University of Science and Technology, Rolla, MO, USA)
A.T. Remaley (National Institutes of Health, Bethesda, MD, USA)
U.S. Ryan (Reddy US Therapeutics Inc., Norcross, GA, USA)
C.S. Samuel (University of Melbourne, Parkville, Australia)
U. Saxena (Dr.Reddy's Laboratories, Norcross, GA, USA)
D.R. Sliskovic (Pfizer Global Research, Ann Arbor, MI, USA)
A. Srivastava (Esperion Therapeutics Inc., Plymouth, MI, USA)
D. Sviridov (Baker Heart Research Institute, Melbourne, Australia)
H. Tilg (Christian Doppler Research Laboratory, Hall in Tyrol, Austria)
N. Tuncel (Eskisehir Osmangazi University, Eskisehir, Turkey)
M.R. Uskokovic (Hoffmann La Roche Inc., Nutley, New Jersey, NJ, USA)
M.R. Wick (University of Virginia, Charlottesville, VA, USA)
M. Yoshimura (The Jikei University school of Medicine, Tokyo, Japan)